SC 13D

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

September 3, 2020

Accession Number

0000875320-20-000034

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →